guest column Expert: Houston has potential to be a major hub for life sciences — if it addresses these concerns Isabella Schmitt
guest column The growing femtech industry needs more attention — and funds, says this Houston expert Isabella Schmitt
fresh funding Houston biotech startup secures $10M seed round to propel cancer-fighting therapy from bench to bedside
